| Ind-Swift Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532305 |
NSE Symbol : INDSWFTLAB |
P/E(TTM) : 39.60 |
|
ISIN Demat : INE915B01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 5.83 |
|
Book Value(₹) : 157.64 |
Market Cap(₹Cr) : 2,007.51 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 172.70 | 153.17 | 150.44 | 147.99 | 149.52 | 121.54 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 172.70 | 153.17 | 150.44 | 147.99 | 149.52 | 121.54 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.21 | 23.89 | 17.86 | 14.58 | 215.52 | 16.63 |
| Total Income | 174.91 | 177.06 | 168.30 | 162.58 | 365.04 | 138.18 |
| Total Expenditure | 157.55 | 149.94 | 148.25 | 144.92 | 158.21 | 123.20 |
| PBIDT | 17.36 | 27.12 | 20.05 | 17.65 | 206.83 | 14.98 |
| Interest | -2.44 | 0.67 | 2.01 | 1.15 | -26.76 | 10.03 |
| PBDT | 19.80 | 26.45 | 18.03 | 16.50 | 233.58 | 4.95 |
| Depreciation | 8.08 | 8.84 | 6.98 | 6.68 | 7.44 | 5.81 |
| Tax | 2.18 | 6.87 | 2.30 | 1.71 | 11.88 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -5.40 | 0.00 | 0.00 | 0.00 | -3.83 | 0.00 |
| Reported Profit After Tax | 14.94 | 10.74 | 8.76 | 8.12 | 218.09 | -0.86 |
| Extra-ordinary Items | -4.19 | -3.57 | 0.00 | 0.00 | 204.54 | -0.73 |
| Adjusted Profit After Extra-ordinary item | 19.13 | 14.31 | 8.76 | 8.12 | 13.55 | -0.13 |
| EPS (Unit Curr.) | 1.79 | 1.32 | 1.10 | 1.18 | 32.34 | -0.13 |
| EPS (Adj) (Unit Curr.) | 1.79 | 1.32 | 1.10 | 1.18 | 32.34 | -0.13 |
| Calculated EPS (Unit Curr.) | 1.72 | 1.32 | 1.07 | 1.18 | 31.72 | -0.15 |
| Calculated EPS (Adj) (Unit Curr.) | 1.72 | 1.32 | 1.07 | 1.18 | 31.72 | -0.15 |
| Calculated EPS (Ann.) (Unit Curr.) | 6.88 | 5.26 | 4.29 | 4.72 | 126.90 | -0.58 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 6.88 | 5.26 | 4.29 | 4.72 | 126.90 | -0.58 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 86.84 | 81.61 | 81.61 | 68.74 | 68.74 | 59.09 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 10.05 | 17.71 | 13.33 | 11.93 | 138.33 | 12.33 |
| PBDTM(%) | 11.46 | 17.27 | 11.98 | 11.15 | 156.22 | 4.07 |
| PATM(%) | 8.65 | 7.01 | 5.82 | 5.49 | 145.86 | -0.71 |
